Herbalife President granted 33,301 stock rights

Rhea-AI Filing Summary

HERBALIFE LTD. President Robert Levy reported an amended insider transaction reflecting a grant of stock appreciation rights. The Form 4/A shows an acquisition of 33,301 stock appreciation rights at an exercise price of $0.00 per right, classified as a grant or award.

The amendment states it was filed solely to correct the previously reported exercise price, which had been shown as $10.51, with no other changes to the original filing. These stock appreciation rights were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan and will vest in three equal installments on February 25, 2027, February 25, 2028, and February 25, 2029, subject to Mr. Levy’s continued service.

Insider Trade Summary

Grant/Award: 33,301 shares

Grant/Award 1 txn

Insider LEVY ROBERT

Role President

Type	Security	Shares	Price	Value
Grant/Award	Stock Appreciation Rights	33,301	$0.00	$0.00

Holdings After Transaction: Stock Appreciation Rights — 33,301 contracts (Direct)

Footnotes (2)

1. F1. This amendment is being filed solely to correct the exercise price, which was previously reported as $10.51. No other information in the original Form 4 has been changed.
2. F2. Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of February 25, 2027, February 25, 2028, and February 25, 2029, subject to continued service through such date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Herbalife (HLF) President Robert Levy report?

Herbalife President Robert Levy reported receiving a grant of 33,301 stock appreciation rights. The award was reported on an amended Form 4/A and represents a compensation-related acquisition rather than an open-market stock purchase or sale.

Why did Herbalife (HLF) file an amended Form 4/A for Robert Levy?

The amended Form 4/A was filed solely to correct the exercise price for Robert Levy’s stock appreciation rights. The prior filing mistakenly showed an exercise price of $10.51, and the amendment states no other information from the original Form 4 changed.

How many stock appreciation rights did Robert Levy receive from Herbalife (HLF)?

Robert Levy received 33,301 stock appreciation rights from Herbalife. These rights are a form of equity-based compensation that can deliver value based on future share price performance rather than being an immediate stock purchase.

When do Robert Levy’s Herbalife (HLF) stock appreciation rights vest?

Robert Levy’s stock appreciation rights vest in three equal installments on February 25, 2027, February 25, 2028, and February 25, 2029. Vesting is conditioned on his continued service with Herbalife through each vesting date.

Under which plan were Robert Levy’s Herbalife (HLF) stock appreciation rights granted?

The stock appreciation rights were granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. This plan authorizes equity-based awards, such as stock appreciation rights, as part of the company’s executive and employee compensation programs.

Is Robert Levy’s Herbalife (HLF) Form 4/A transaction a stock purchase or sale?

Robert Levy’s Form 4/A does not report a stock purchase or sale in the open market. It reports an acquisition of 33,301 stock appreciation rights as a grant or award, which is a compensation-related derivative security.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 09:25 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LEVY ROBERT

(Last) (First) (Middle)

800 WEST OLYMPIC BLVD.

SUITE 406

(Street)

LOS ANGELES CA 90015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HERBALIFE LTD. [ HLF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)
02/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Appreciation Rights	$19.26(1)	02/25/2026		A		33,301		(2)	02/25/2036	Common Stock	33,301	$0	33,301	D

Explanation of Responses:

1. This amendment is being filed solely to correct the exercise price, which was previously reported as $10.51. No other information in the original Form 4 has been changed.

2. Consists of stock appreciation rights ("SARs") granted under the Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in one-third increments on each of February 25, 2027, February 25, 2028, and February 25, 2029, subject to continued service through such date.

	/s/ Alaaeddine Sahibi, as Attorney-In-Fact for Robert Levy	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.